RPID
Rapid Micro Biosystems Inc
$
2.990
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.0699
Open
2.900
VWAP
2.99
Vol
28.10K
Mkt Cap
132.19M
Low
2.8216
Amount
84.01K
EV/EBITDA(TTM)
--
Total Shares
42.86M
EV
100.00M
EV/OCF(TTM)
--
P/S(TTM)
4.35
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
8.90M
+23.53%
-0.210
-19.23%
9.83M
+19.55%
-0.217
-1.14%
7.60M
-0.05%
-0.245
-5.77%
Estimates Revision
The market is revising No Change the revenue expectations for Rapid Micro Biosystems, Inc. (RPID) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -14.33%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-14.33%
In Past 3 Month
3 Analyst Rating
Wall Street analysts forecast RPID stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RPID is 8.00 USD with a low forecast of 8.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 2.990
Low
8.00
Averages
8.00
High
8.00
Current: 2.990
Low
8.00
Averages
8.00
High
8.00
Lake Street
NULL -> Buy
initiated
$8
2025-07-28
Reason
Lake Street
Price Target
$8
2025-07-28
initiated
NULL -> Buy
Reason
Lake Street initiated coverage of Rapid Micro Biosystems with a Buy rating and $8 price target. Rapid is "emerging as the category leader" in microbial quality control automation with its Growth Direct platform, says the analyst, who believes the market has yet to fully appreciate the already existing scale and growing adoption of Growth Direct. The firm sees further upside as recurring revenue continues to scale given "the stickiness of the platform," the analyst added.
Keybanc
Paul Knight
Buy
Initiates
$8
2025-02-12
Reason
Keybanc
Paul Knight
Price Target
$8
2025-02-12
Initiates
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Rapid Micro Biosystems Inc (RPID.O) is -3.43, compared to its 5-year average forward P/E of -3.29. For a more detailed relative valuation and DCF analysis to assess Rapid Micro Biosystems Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-3.29
Current PE
-3.43
Overvalued PE
0.67
Undervalued PE
-7.25
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-1.96
Current EV/EBITDA
-2.63
Overvalued EV/EBITDA
3.94
Undervalued EV/EBITDA
-7.85
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
6.43
Current PS
2.99
Overvalued PS
14.63
Undervalued PS
-1.76
Financials
Annual
Quarterly
FY2025Q2
YoY :
+9.73%
7.26M
Total Revenue
FY2025Q2
YoY :
-9.19%
-12.15M
Operating Profit
FY2025Q2
YoY :
-5.72%
-11.86M
Net Income after Tax
FY2025Q2
YoY :
-6.90%
-0.27
EPS - Diluted
FY2025Q2
YoY :
-4.84%
-10.07M
Free Cash Flow
FY2025Q2
YoY :
-232.52%
3.79
Gross Profit Margin - %
FY2025Q2
YoY :
-33.22%
-126.38
FCF Margin - %
FY2025Q2
YoY :
-14.09%
-163.29
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
196.0K
USD
5
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
2
20.4K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
196.0K
USD
5
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
2
20.4K
USD
Months
RPID News & Events
Events Timeline
2025-09-22 (ET)
2025-09-22
08:13:01
Trinity Capital invests $45 million in growth funding for Rapid Micro Biosystems.
2025-08-12 (ET)
2025-08-12
06:35:32
Rapid Micro Biosystems reports Q2 EPS (27c), consensus (25c)
2025-05-27 (ET)
2025-05-27
09:12:46
Rapid Micro Biosystems appoints Bika to board of directors
Sign Up For More Events
Sign Up For More Events
News
1.0
10-30NewsfilterRapid Micro Biosystems to Attend the Stifel 2025 Healthcare Conference
8.5
09-22PRnewswireTrinity Capital Inc. Provides $45 Million in Growth Capital to Rapid Micro Biosystems, Modernizing Healthcare Industry Practices
9.5
08-12NASDAQ.COMRapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
Sign Up For More News
People Also Watch
OTLK
Outlook Therapeutics Inc
1.260
USD
+1.61%
SPRU
Spruce Power Holding Corp
2.800
USD
-3.45%
OVID
Ovid Therapeutics Inc
1.390
USD
+1.46%
GROV
Grove Collaborative Holdings Inc
1.360
USD
+2.26%
MAIA
Maia Biotechnology Inc
1.240
USD
-5.34%
PVL
Permianville Royalty Trust
1.844
USD
+0.22%
FTCI
FTC Solar Inc
8.820
USD
+2.50%
AP
Ampco-Pittsburgh Corp
2.100
USD
-2.78%
FAQ
What is Rapid Micro Biosystems Inc (RPID) stock price today?
The current price of RPID is 2.99 USD — it has increased 2.75 % in the last trading day.
What is Rapid Micro Biosystems Inc (RPID)'s business?
What is the price predicton of RPID Stock?
What is Rapid Micro Biosystems Inc (RPID)'s revenue for the last quarter?
What is Rapid Micro Biosystems Inc (RPID)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Rapid Micro Biosystems Inc (RPID)'s fundamentals?
How many employees does Rapid Micro Biosystems Inc (RPID). have?